# Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

> **NCT00234819** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 325 (—)

## Conditions studied

- Vasomotor Symptoms Associated With Menopause

## Interventions

- **DRUG:** Bazedoxifene/Conjugated Estrogen

## Key facts

- **NCT ID:** NCT00234819
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 325 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234819, "Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00234819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*